Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms

Majority of patients with metastatic castrate resistant prostate cancer (mCRPC) develop bone metastases which results in significant morbidity and mortality as a result of skeletal-related events (SREs). Several bone-targeted agents are either in clinical use or in development for prevention of SREs...

Full description

Saved in:
Bibliographic Details
Main Authors: El-Amm, Joelle, Freeman, Ashley, Patel, Nihar, Aragon-Ching, Jeanny B.
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2013
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3771418/
https://ncbi.nlm.nih.gov/pubmed/24069538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/210686
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items